AU2001240543A1 - Cytostatic agent glycoconjugate - Google Patents
Cytostatic agent glycoconjugateInfo
- Publication number
- AU2001240543A1 AU2001240543A1 AU2001240543A AU4054301A AU2001240543A1 AU 2001240543 A1 AU2001240543 A1 AU 2001240543A1 AU 2001240543 A AU2001240543 A AU 2001240543A AU 4054301 A AU4054301 A AU 4054301A AU 2001240543 A1 AU2001240543 A1 AU 2001240543A1
- Authority
- AU
- Australia
- Prior art keywords
- glycoconjugate
- cytostatic agent
- cytostatic
- agent
- agent glycoconjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000824 cytostatic agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10005275 | 2000-02-07 | ||
| DE10005275A DE10005275A1 (en) | 2000-02-07 | 2000-02-07 | Novel glycoconjugates |
| PCT/EP2001/000793 WO2001058932A1 (en) | 2000-02-07 | 2001-01-25 | Cytostatic agent glycoconjugate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001240543A1 true AU2001240543A1 (en) | 2001-08-20 |
Family
ID=7630059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001240543A Abandoned AU2001240543A1 (en) | 2000-02-07 | 2001-01-25 | Cytostatic agent glycoconjugate |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001240543A1 (en) |
| DE (1) | DE10005275A1 (en) |
| WO (1) | WO2001058932A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
| GB0329667D0 (en) | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
| GB0513881D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
| GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
| RU2696487C2 (en) * | 2013-03-06 | 2019-08-02 | Аллерган, Инк. | Using formylpeptide receptor 2 agonists for treating dermatologic diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4106101A1 (en) * | 1991-02-27 | 1992-09-03 | Bayer Ag | FUCOSE-MARKED CYTOSTATICS |
| IL105503A (en) * | 1992-04-28 | 1999-05-09 | Astra Ab | Peptide-carbohydrate conjugates capable of generating t cell immunity |
| DE4436164A1 (en) * | 1994-10-10 | 1996-04-11 | Hoechst Ag | New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| DE19512484A1 (en) * | 1995-04-04 | 1996-10-17 | Bayer Ag | Carbohydrate modified cytostatics |
| JP2001504453A (en) * | 1996-09-30 | 2001-04-03 | バイエル・アクチエンゲゼルシヤフト | Glycoconjugates from modified camptothecin derivatives (20-O-linked) |
| ID23424A (en) * | 1997-05-14 | 2000-04-20 | Bayer Ag | GLIKOKONJUGUS OF 20 (S) -CAMPTOTESIN |
-
2000
- 2000-02-07 DE DE10005275A patent/DE10005275A1/en not_active Withdrawn
-
2001
- 2001-01-25 WO PCT/EP2001/000793 patent/WO2001058932A1/en not_active Ceased
- 2001-01-25 AU AU2001240543A patent/AU2001240543A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001058932A1 (en) | 2001-08-16 |
| DE10005275A1 (en) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001246876A1 (en) | Remedies | |
| AU2001246877A1 (en) | Remedies | |
| AU2001288040A1 (en) | Homeostasis-maintaining agents | |
| AU2000267458A1 (en) | Hypercomputer | |
| AU2001254546A1 (en) | Aminopiperidines | |
| AU2002224595A1 (en) | Antitumor agents | |
| AU2002214284A1 (en) | Anti-helicobacterial agents | |
| AU2001220246A1 (en) | Neckphone | |
| AU2001239310A1 (en) | Decahydro-isoquinolines | |
| AU4647601A (en) | Vascular device | |
| AU2001280598A1 (en) | Anti-occlusion catheter | |
| EP1151667A3 (en) | Plant-activating agent | |
| AU2001258349A1 (en) | Bisacylguanidine | |
| AU2001258924A1 (en) | Microsatellite-aflp | |
| AU2002330717A1 (en) | Monosaccharide derivatives | |
| AU1554301A (en) | Radioprotecting agent | |
| AU2001234178A1 (en) | Modified bdnf | |
| AU2001232244A1 (en) | Drug comprising combination | |
| AU2001246864A1 (en) | Hypotensors | |
| AU2001240543A1 (en) | Cytostatic agent glycoconjugate | |
| AU2001226668A1 (en) | Crankshaft-starter-generator | |
| EP1201403A3 (en) | Electrofusible units | |
| AU2001275696A1 (en) | Therapeutic agent | |
| AUPR024300A0 (en) | Tissue bonding agent | |
| AU2001260192A1 (en) | Glycinamides |